187 related articles for article (PubMed ID: 36175940)
1. Acute pancreatitis in pregnancy following COVID-19 vaccine: a case report.
Dey RK; Ilango H; Bhatta S; Shaheed A; Dole S; Zooshan A; Faisham M; Murad M
J Med Case Rep; 2022 Sep; 16(1):354. PubMed ID: 36175940
[TBL] [Abstract][Full Text] [Related]
2. Acute pancreatitis soon after COVID-19 vaccination: A case report.
Ozaka S; Kodera T; Ariki S; Kobayashi T; Murakami K
Medicine (Baltimore); 2022 Jan; 101(2):e28471. PubMed ID: 35029194
[TBL] [Abstract][Full Text] [Related]
3. Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine.
Stöllberger C; Kastrati K; Dejaco C; Scharitzer M; Finsterer J; Bugingo P; Melichart-Kotik M; Wilfing A
Wien Klin Wochenschr; 2023 Aug; 135(15-16):436-440. PubMed ID: 37280395
[TBL] [Abstract][Full Text] [Related]
4. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
[TBL] [Abstract][Full Text] [Related]
5. Acute Pancreatitis: A Possible Side Effect of COVID-19 Vaccine.
Parkash O; Sharko A; Farooqi A; Ying GW; Sura P
Cureus; 2021 Apr; 13(4):e14741. PubMed ID: 34084669
[TBL] [Abstract][Full Text] [Related]
6. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine.
Nomura J; Seki M; Abe S; Kobayashi T; Okitsu Y; Fukuhara N; Takahashi S; Harigae H; Kameoka J
Hum Vaccin Immunother; 2023 Dec; 19(1):2165381. PubMed ID: 36625832
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review.
N AM; Saleh AM; Khalid A; Alshaya AK; Alanazi SMM
Clin Rheumatol; 2022 May; 41(5):1577-1582. PubMed ID: 35175446
[TBL] [Abstract][Full Text] [Related]
8. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
[TBL] [Abstract][Full Text] [Related]
9. Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine.
Muhamad Fauzi SM
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882264
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
11. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
Park S; You J
J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
14. New-onset retroperitoneal fibrosis following COVID-19 mRNA vaccination: Coincidental or vaccine-induced phenomenon?
Ture HY; Kim NR; Nam EJ
Int J Rheum Dis; 2023 Jul; 26(7):1368-1372. PubMed ID: 36814401
[TBL] [Abstract][Full Text] [Related]
15. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
[TBL] [Abstract][Full Text] [Related]
16. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.
Alzoabi N; Alqahtani J; Algamdi B; Almutairi M; Alratroot J; Alkhaldi S; Alqahtani S; Alakloby O
Med Arch; 2022 Feb; 76(1):72-74. PubMed ID: 35422564
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
18. Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine.
Inoue M; Yasue Y; Kobayashi Y; Sugiyama Y
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35292552
[TBL] [Abstract][Full Text] [Related]
19. Acute idiopathic pancreatitis in pregnancy: a case study.
Kim JY; Jung SH; Choi HW; Song DJ; Jeong CY; Lee DH; Whang IS
World J Gastroenterol; 2014 Nov; 20(43):16364-7. PubMed ID: 25473197
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough Severe COVID-19 Infection After Triple Dose Pfizer Vaccination.
Khalil F; Badshah M; Perinkulam Sathyanarayanan S; Lamfers R
S D Med; 2022 Apr; 75(4):171-174. PubMed ID: 35709349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
